September 20, 2014 5:18 PM ET


Company Overview of Aesgen Inc.

Company Overview

Aesgen, Inc. focuses on treating the side effects associated with cancer treatments. It offers Saforis oral suspension product, which is a phase three product candidate in development for treatment of oral mucositis. As of September 28, 2004, Aesgen, Inc. operates as a subsidiary of MGI Pharma Inc.

Wilmington, NC 

United States

Key Executives for Aesgen Inc.

Chief Financial Officer
Age: 49
Vice President
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Biotic Laboratories, Inc. United States
Abiomed R&D, Inc. United States
Ras Therapeutics, Inc. United States
MyGene International Inc. United States
Biomoda Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aesgen Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at